InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Brager David A., Director. Officer active across 2 companies, notably CVB FINANCIAL CORP. In total, 13 filings have been published. Activity tracked since 19 September 2021. The latest transaction was filed on 25 March 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations13 total
1,974 shares@ US$23.980.0017% mcap13.0% of flowCommon StockSEC:0001567619-22-007622:0
21,350 shares0Common StockSEC:0001567619-22-001940:0
3,408 shares@ US$22.280.0027% mcap20.5% of flowCommon StockSEC:0001567619-22-001967:0
21,350 shares0Common StockSEC:0001567619-22-001940
3,408 shares@ US$22.2847.0% of flowCommon StockSEC:0001567619-22-001967
20,850 shares0Common StockSEC:0001567619-22-001881
20,850 shares0Common StockSEC:0001567619-22-001881:0
519 shares@ US$20.670.0004% mcap2.8% of flowCommon StockSEC:0001567619-21-020708:0
519 shares@ US$20.670.0004% mcap2.8% of flowCommon StockSEC:0001567619-21-020708
1,496 shares@ US$19.850.0010% mcap7.7% of flowCommon StockSEC:0001567619-21-018506:0
1,496 shares@ US$19.8517.8% of flowCommon StockSEC:0001567619-21-018506
2,500 shares@ US$19.310.0016% mcap12.5% of flowCommon StockSEC:0001567619-21-017420:0
2,500 shares@ US$19.3128.7% of flowCommon StockSEC:0001567619-21-017420
13 of 13 declarations
About Brager David A.
Franklin M. Berger is a Board Member at Kezar Life Sciences, Inc. and Rain Therapeutics Inc. He brings expertise in biopharmaceutical strategy to the board. His role involves overseeing growth initiatives and ensuring that operations align with the company's goals.
